| P2093 | author name string | M R Daha | |
| | T E Mollnes | |
| | G Posthuma | |
| | P C Aerts | |
| | H van Dijk | |
| | A Fleer | |
| | J J Roord | |
| | C Neeleman | |
| | S P Geelen | |
| P2860 | cites work | The role of complement in inflammation during experimental pneumococcal meningitis | Q57077299 |
| | Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae | Q67248843 |
| | Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies | Q68853521 |
| | Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex | Q68941679 |
| | Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production | Q70018803 |
| | The critical role of complement in experimental pneumococcal sepsis | Q71481006 |
| | Estimation of classical pathway of mouse complement activity by use of sensitized rabbit erythrocytes | Q71534013 |
| | PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice | Q71619831 |
| | Degradation of C3 by Streptococcus pneumoniae | Q72166949 |
| | Molecular analysis of putative pneumococcal virulence proteins | Q73237060 |
| | Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat | Q24644391 |
| | Streptococcal M protein: molecular design and biological behavior. | Q30382858 |
| | PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type | Q33513623 |
| | Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. | Q33558301 |
| | Pneumolysin: a multifunctional pneumococcal virulence factor | Q34454932 |
| | Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. | Q35104954 |
| | Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae | Q35111311 |
| | Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae | Q35532255 |
| | Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA | Q36107664 |
| | Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae | Q36349356 |
| | Membrane location of a deoxyribonuclease implicated in the genetic transformation of Diplococcus pneumoniae | Q36611400 |
| | A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia | Q37013921 |
| | Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974 | Q37350447 |
| | Pneumococcal type-associated variability in alternate complement pathway activation | Q39063946 |
| | Classical and alternative complement pathway activation by pneumococci | Q39159842 |
| | Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. | Q39820920 |
| | Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. | Q39821276 |
| | Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. | Q40056277 |
| | The Role of Antibody and Complement in the Reticuloendothelial Clearance of Pneumococci from the Bloodstream | Q40161697 |
| | The epidemiology of pneumococcal disease in infants and children. | Q40310229 |
| | The role of complement in the host's defense against Streptococcus pneumoniae. | Q40310244 |
| | Pneumococcal virulence factors and host immune responses to them | Q40432501 |
| | Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae | Q41080026 |
| | Improving structural integrity of cryosections for immunogold labeling | Q41153038 |
| | Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. | Q41274022 |
| | Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice | Q41677341 |
| | Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma | Q43762567 |
| | Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987 | Q44903059 |
| | The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system | Q46609944 |
| | Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9. | Q46805574 |
| | SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component | Q48043357 |
| | An epidemiologic approach to pneumococcal disease. | Q53949240 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phagocytosis | Q184726 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 4517-4524 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. | |
| P478 | volume | 67 | |